Moat Ross — SEC insider filings

SEC reporting owner CIK 1857177. 26 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2021-09-07 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICER26—22 legs · 322,928 sh · $15,453,887159

Insider filings — Moat Ross

FiledFormIssuerReported transactionsSource
2026-11-034Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 16,111 @ $10.76 · Option exercise (M): 21,059 @ $11.10 · Option exercise (M): 3,760 @ $11.97 · Option exercise (M): 1,658 @ $12.97 · Option exercise (M): 16,112 @ $17.76 · Option exercise (M): 10,895 @ $18.06 · +23 moreEDGAR
2026-09-034Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 2,477 · Option exercise (M): 1,611 · Option exercise (M): 1,740 · Option exercise (M): 2,457 · Tax withholding (F): 4,007 @ $79.28 · Grant/award (A): 9,250 (derivative) @ $0 · +5 moreEDGAR
2026-04-134Kiniksa Pharmaceuticals International, plc (KNSA)Sale (S): 1,703 @ $46.69EDGAR
2026-04-084Kiniksa Pharmaceuticals International, plc (KNSA)Sale (S): 2,367 @ $48.58 · Option exercise (M): 2,477 · Tax withholding (F): 774 @ $48.94 · Option exercise (M): 2,477 (derivative) @ $0EDGAR
2026-04-034Kiniksa Pharmaceuticals International, plc (KNSA)Grant/award (A): 879 @ $24.16 · Option exercise (M): 5,808 · Tax withholding (F): 1,706 @ $48.13 · Grant/award (A): 36,950 (derivative) @ $0 · Grant/award (A): 9,250 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · +3 moreEDGAR
2025-09-084Kiniksa Pharmaceuticals International, plc (KNSA)Sale (S): 3,523 @ $35.31EDGAR
2025-09-034Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 1,741 · Option exercise (M): 1,611 · Option exercise (M): 2,477 · Tax withholding (F): 2,819 @ $33.49 · Option exercise (M): 994 · Tax withholding (F): 481 @ $34.28 · +6 moreEDGAR
2025-06-054Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 27,594 @ $13.35 · Sale (S): 27,594 @ $29.02 · Option exercise (M): 27,594 (derivative) @ $0EDGAR
2025-05-054Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 3,850 @ $17.76 · Sale (S): 3,850 @ $28 · Option exercise (M): 6,272 @ $17.76 · Sale (S): 6,272 @ $28 · Grant/award (A): 4,976 (derivative) @ $0 · Grant/award (A): 5,225 (derivative) @ $0 · +4 moreEDGAR
2025-05-014Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 15,000 @ $15.52 · Option exercise (M): 20,000 @ $15.50 · Option exercise (M): 6,296 @ $12.97 · Option exercise (M): 7,432 @ $11.97 · Option exercise (M): 15,307 @ $10.76 · Sale (S): 64,035 @ $25.21 · +12 moreEDGAR
2025-04-234Kiniksa Pharmaceuticals International, plc (KNSA)Sale (S): 18,259 @ $20.29EDGAR
2025-04-094Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 2,477 · Tax withholding (F): 727 @ $20.28 · Option exercise (M): 2,477 (derivative) @ $0EDGAR
2025-04-034Kiniksa Pharmaceuticals International, plc (KNSA)Option exercise (M): 1,611 · Option exercise (M): 1,741 · Tax withholding (F): 473 @ $21.77 · Tax withholding (F): 511 @ $21.77 · Grant/award (A): 39,364 (derivative) @ $0 · Grant/award (A): 9,828 (derivative) @ $0 · +3 moreEDGAR
2025-03-194Kiniksa Pharmaceuticals International, plc (KNSA)Grant/award (A): 1,118 @ $16 · Option exercise (M): 994 · Tax withholding (F): 292 @ $22.61 · Option exercise (M): 994 (derivative) @ $0EDGAR
2024-09-044Kiniksa Pharmaceuticals International, plc (KNSA)Grant/award (A): 211 @ $15.65 · Option exercise (M): 4,089 · Tax withholding (F): 1,393 @ $26.74 · Option exercise (M): 994 · Tax withholding (F): 345 @ $26.74 · Option exercise (M): 14,000 @ $8.83 · +12 moreEDGAR
2024-04-084Kiniksa Pharmaceuticals, Ltd. (KNSA)Option exercise (M): 2,477 · Tax withholding (F): 1,353 @ $17.90 · Grant/award (A): 36,100 (derivative) @ $0 · Grant/award (A): 5,569 (derivative) @ $0 · Grant/award (A): 6,962 (derivative) @ $0 · Option exercise (M): 2,477 (derivative) @ $0EDGAR
2024-04-034Kiniksa Pharmaceuticals, Ltd. (KNSA)Option exercise (M): 1,612 · Tax withholding (F): 880 @ $19.70 · Option exercise (M): 1,612 (derivative) @ $0EDGAR
2023-09-064Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 292 @ $12.35 · Option exercise (M): 2,477 · Tax withholding (F): 1,353 @ $17.76 · Option exercise (M): 994 · Tax withholding (F): 543 @ $17.76 · Option exercise (M): 2,477 (derivative) @ $0 · +3 moreEDGAR
2023-04-114Kiniksa Pharmaceuticals, Ltd. (KNSA)Option exercise (M): 2,477 · Tax withholding (F): 1,353 @ $10.71 · Option exercise (M): 2,477 (derivative) @ $0EDGAR
2023-04-034Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 38,668 (derivative) @ $0 · Grant/award (A): 6,445 (derivative) @ $0EDGAR
2023-03-204Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 1,844 @ $9.56 · Option exercise (M): 994 · Tax withholding (F): 543 @ $11.46 · Option exercise (M): 2,137 · Tax withholding (F): 1,167 @ $11.12 · Option exercise (M): 994 (derivative) @ $0 · +1 moreEDGAR
2022-09-064Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 360 @ $9.56 · Option exercise (M): 995 · Tax withholding (F): 563 @ $11.44 · Grant/award (A): 59,460 (derivative) @ $0 · Grant/award (A): 9,908 (derivative) @ $0 · Option exercise (M): 995 (derivative) @ $0EDGAR
2022-04-114Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 59,460 (derivative) @ $0 · Grant/award (A): 9,908 (derivative) @ $0EDGAR
2022-03-234Kiniksa Pharmaceuticals, Ltd. (KNSA)Option exercise (M): 2,270 · Tax withholding (F): 1,240 @ $10.98 · Option exercise (M): 2,270 (derivative) @ $0EDGAR
2022-03-184Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 963 @ $11.49 · Grant/award (A): 1,546 @ $9.63 · Option exercise (M): 995 · Tax withholding (F): 544 @ $10.13 · Option exercise (M): 995 (derivative) @ $0EDGAR
2021-09-074Kiniksa Pharmaceuticals, Ltd. (KNSA)Grant/award (A): 7,954 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1857177 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs